Monitoring Noninvasively for Infusion and Transfusion Optimization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04388722|
Recruitment Status : Withdrawn (Sponsor's decision to withdraw study.)
First Posted : May 14, 2020
Last Update Posted : December 14, 2020
Information provided by (Responsible Party):
This is a multicenter, cluster randomized controlled trial to assess the effects of an optimized intraoperative fluid and blood management strategy on postoperative complications.
|Condition or disease||Intervention/treatment||Phase|
|Post Operative Hemorrhage Transfusion Related Complication Blood Transfusion Associated Adverse Reactions Hypovolemia||Device: Pulse CO-Oximeter Sensor||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Monitoring Noninvasively for Infusion and Transfusion Optimization in a Randomized (MONITOR) Trial|
|Estimated Study Start Date :||December 10, 2020|
|Estimated Primary Completion Date :||December 10, 2020|
|Estimated Study Completion Date :||December 10, 2020|
|No Intervention: Control Arm|
|Experimental: Investigational Arm||
Device: Pulse CO-Oximeter Sensor
Investigational Pulse CO-Oximeter sensor will measure hemoglobin (SpHb) and pleth variability index (PVi).
Primary Outcome Measures :
- Post-operative complication [ Time Frame: 7 days ]Occurrence of at least one post-operative complication by day 7 after surgery.
No Contacts or Locations Provided